C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 5/10 (2006.01) A61K 31/52 (2006.01) A61K 31/70 (2006.01) A61K 35/12 (2006.01) A61K 39/00 (2006.01) C12N 5/06 (2006.01) C12N 15/90 (2006.01) A61K 48/00 (2006.01)
Patent
CA 2113990
2113990 9302556 PCTABS00019 A method is provided for eliminating cancer cells from a population of cells containing cancer cells and noncancerous cells in vitro) or in vivo comprising: (a) providing a mixture of noncancerous cells and cancer cells; (b) contacting the cancer cells with transgenic cancer cells comprising a foreign gene that renders the transgenic cancer cells susceptible to a therapeutic agent; and (c) contacting the transgenic cancer cells with an amount of said therapeutic agent effective to kill both the transgenic cancer cells and the cancer cells.
Abraham George N.
Freeman Scott M.
Koeplin David
Mccune Craig S.
Moolten Frederick L.
Koeplin David
Moolten Frederick L.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
University Of Rochester
LandOfFree
Cancer therapy utilizing malignant cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cancer therapy utilizing malignant cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cancer therapy utilizing malignant cells will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1624437